Wigen Biomedicine Technology (shanghai) Co., Ltd.

This early-stage study is testing the safety and initial effectiveness of a new drug, WJB001, when combined with various other cancer therapies. It will involve about 86 adults with advanced solid tumors who have run out of standard treatment options. The main goals are to find s…